Request availability and a quotation for your required quantity and destination.
| Product | Minoxidil 5% + Tretinoin 0.01% + Azelaic Acid 1.5% - ReAttain-AT |
|---|---|
| Categories | Hair Care |
| Availability | Confirmed on enquiry |
Product listing is not a recommendation to use this medicine. Prescription and destination requirements apply where relevant.
Product category: Hair Care
Topical scalp solution with three listed active ingredients. This compounded-style combination is not an FDA-approved fixed-dose hair-loss formulation. The original pack must be checked for full ingredients, concentrations and instructions.
Minoxidil is used for certain types of androgenetic hair loss. Tretinoin influences skin turnover and may affect absorption; azelaic acid has dermatological uses, but evidence is insufficient to claim this exact three-drug formula is superior to standard topical minoxidil.
Use only according to verified manufacturer instructions and professional advice. Avoid inflamed or damaged scalp, the eyes and mucous membranes. Tretinoin can increase irritation and sun sensitivity.
Redness, dryness, burning, scaling and scalp irritation can occur. Systemic minoxidil absorption may cause palpitations, dizziness or swelling. Pregnancy or planned pregnancy requires clinical advice because topical retinoids are generally avoided.
Tugain 5 topical minoxidil · Avodart dutasteride. These are distinct treatments, not interchangeable products.
FDA labeling: topical minoxidil
Its minoxidil component may help selected cases, but the exact combination has not been established as more effective.
It also lists tretinoin and azelaic acid, which may change tolerability; comparative evidence is limited.
Hair growth response can take several months and varies by person.
Some people experience temporary shedding with minoxidil; unusually severe shedding needs review.
Yes, particularly with tretinoin in the formula.
No, seek professional advice before using on irritated or broken skin.
Do not use without professional assessment; topical retinoids are generally avoided.
Only if a clinician specifically assesses systemic risks.
Additional retinoids can increase irritation; discuss with a dermatologist.
Any maintained regrowth from minoxidil may gradually be lost.
Cureiva provides educational product information and handles lawful enquiries subject to prescriptions, product verification and destination-country rules. This is not individual medical advice or a claim of clinician sign-off. Updated October 2026.